Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Irina, Lyakhova"'
Autor:
Irina, Lyakhova, Mariia, Piatkova, Yuri, Khotimchenko, Maxim, Zhidkov, Alexey, Kantemirov, Rodion, Khotimchenko, Andrey, Bryukhovetskiy, Aruna, Sharma, Hari Shanker, Sharma, Igor, Bryukhovetskiy
Publikováno v:
International review of neurobiology. 151
Glioblastoma (GB) is one of the most aggressive human brain tumors. The prognosis is unfavorable, its treatment is relatively ineffective, and the median survival is about 15months. Medication development with new chemical compounds is one of the way
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e332ffa0971ae55f61d2120c2d5680e
https://pubmed.ncbi.nlm.nih.gov/32448614
https://pubmed.ncbi.nlm.nih.gov/32448614
Autor:
Irina, Lyakhova, Mariia, Piatkova, Valeriia, Gulaia, Aleksandr, Romanishin, Mikhail, Shmelev, Andrey, Bryukhovetskiy, Aruna, Sharma, Hari Shanker, Sharma, Rodion, Khotimchenko, Igor, Bryukhovetskiy
Publikováno v:
International review of neurobiology. 151
Glioblastoma is one of the most aggressive human brain tumors. Even following all the modern protocols of complex treatment, the median patient survival typically does not exceed 15 months. This review analyzes the main reasons for glioblastoma resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd28666f24dd485801d54bbcf8a8d442
https://pubmed.ncbi.nlm.nih.gov/32448613
https://pubmed.ncbi.nlm.nih.gov/32448613
Autor:
Igor Bryukhovetskiy, Maxim E. Zhidkov, Irina Lyakhova, Aruna Sharma, Andrey Bryukhovetskiy, Mariia A. Piatkova, Yuri Khotimchenko, Alexey Kantemirov, Hari Shanker Sharma, Rodion Khotimchenko
Glioblastoma (GB) is one of the most aggressive human brain tumors. The prognosis is unfavorable, its treatment is relatively ineffective, and the median survival is about 15 months. Medication development with new chemical compounds is one of the wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e97d1bc0ebd477c203331133bd4384f5
https://doi.org/10.1016/bs.irn.2020.03.011
https://doi.org/10.1016/bs.irn.2020.03.011
Autor:
Irina Lyakhova, Valeriia Gulaia, Mikhail E. Shmelev, Igor Bryukhovetskiy, Andrey Bryukhovetskiy, Aleksandr Romanishin, Mariia A. Piatkova, Aruna Sharma, Hari Shanker Sharma, Rodion Khotimchenko
Glioblastoma is one of the most aggressive human brain tumors. Even following all the modern protocols of complex treatment, the median patient survival typically does not exceed 15 months. This review analyzes the main reasons for glioblastoma resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f418c01ebb9ad7105edb1a0835782e71
https://doi.org/10.1016/bs.irn.2020.03.010
https://doi.org/10.1016/bs.irn.2020.03.010
Publikováno v:
Tetrahedron Letters. 59:1417-1420
A method for one-step conversion of the marine alkaloid fascaplysin into homofascaplysins B and B-1 was elaborated. It was also used for the first syntheses of the marine alkaloids 3–bromohomofascaplysin B and 3-bromohomofascaplysin B-1. The best r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e324c5cadf5d24250066c83a551a2bc
https://doi.org/10.1016/j.tetlet.2018.02.070
https://doi.org/10.1016/j.tetlet.2018.02.070
Autor:
Andrey Bryukhovetskiy, Irina Lyakhova, Maxim Khotimchenko, Yuri Khotimchenko, Igor Kudryavtsev, Maxim E. Zhidkov, Polina Mischenko, Elena Milkina, Igor Bryukhovetskiy, Alexander Polevshchikov, Sergei Zaitsev
Publikováno v:
Oncology Letters
Glioblastoma multiforme is an invasive malignant glial brain tumor with a poor prognosis for patients. The primary reasons that lead to the development of treatment resistance are associated with tumor cells infiltrating the brain parenchyma and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056cba43a78fd06f893c9bce9e3b0629
https://doi.org/10.3892/ol.2016.5478
https://doi.org/10.3892/ol.2016.5478
Autor:
Irina Lyakhova, Arina Ponomarenko, Maria Korneyko, S. Zaitsev, Igor Bryukhovetskiy, Yuri Khotimchenko, M. G. Eliseikina, Polina Mischenko, Yulia Zayats, Valeryi Shevchenko, Hari Shanker Sharma, Elena Milkina
Publikováno v:
Oncology Reports.
The majority of modern treatment methods for malignant brain tumors are not sufficiently effective, with a median survival time varying between 9 and 14 months. Metastatic and invasive processes are the principal characteristics of malignant tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73411a24134617fe5d6c76afb0608d21
https://doi.org/10.3892/or.2018.6671
https://doi.org/10.3892/or.2018.6671
Autor:
Irina Lyakhova, Arina Ponomarenko, Igor Bryukhovetskiy, Yuri Khotimchenko, S. Zaitsev, Aruna Sharma, Polina Mischenko, Maria Korneyko, Valerie Shevchenko, Yulia Zayats, M. G. Eliseikina, Hari Shanker Sharma
Publikováno v:
International Journal of Molecular Medicine
Glioblastoma multiforme (GBM) is one of the most aggressive brain tumors. GBM represents >50% of primary tumors of the nervous system and similar to 20% of intracranial neoplasms. Standard treatment involves surgery, radiation and chemotherapy. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a24a6cdea6aaefd9bc892513ff08e5
https://pubmed.ncbi.nlm.nih.gov/29749540
https://pubmed.ncbi.nlm.nih.gov/29749540
Autor:
Igor Bryukhovetskiy, Yuri Khotimchenko, Irina Lyakhova, N. Arnotskaya, V. Shevchenko, S. Zaitsev
Publikováno v:
Annals of Oncology. 30:xi8
Background Invasive growth of glioblastoma multiforme (GBM) is associated with CD133 + cancer stem cells (CSCs) and differentiated CD133- glioblastoma cells (DGCs) formed under the influence of transforming growth factor (TGF-β). The aim of the stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5cc62d0420e9266b7b44a7d1fdba493
https://doi.org/10.1093/annonc/mdz447.024
https://doi.org/10.1093/annonc/mdz447.024
Autor:
Igor Bryukhovetskiy, Yuri Khotimchenko, Y Zayats, A Ponomarenko, Irina Lyakhova, S. Zaitsev, M Korneyko
Publikováno v:
Annals of Oncology. 28:vii30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0fb9fdec7f419c355ba12d7ce491616
https://doi.org/10.1093/annonc/mdx513.010
https://doi.org/10.1093/annonc/mdx513.010